Storytel
Storytel, founded in Stockholm in 2005, is a streaming service for audiobooks and eBooks. It offers over 1.8 million titles in 55 languages to about 2.7 million subscribers and is publicly listed (NASDAQ Stockholm).
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
About Storytel
Storytel is one of the world's leading audiobook and eBook streaming services, founded in 2005 in Stockholm. Over twenty years, the Swedish startup built one of the world's largest digital audio libraries โ over 1.8 million titles in dozens of languages โ and a subscription model that transformed book consumption into an on-demand experience accessible everywhere, covering everything from international bestsellers to local fiction in every market. Growth in 2025 was solid: in Q3, Storytel surpassed 2.6 million paying subscribers โ 9% growth year-on-year at constant exchange rates โ with quarterly revenues exceeding one billion Swedish kronor for the first time. Even more significant is the profitability improvement: adjusted EBITDA grew 26% to SEK 224 million in Q3 2025, with a 22.1% margin โ a company record. Storytel is listed on the Stockholm Stock Exchange and operates in 25+ markets. The model is based on monthly all-you-can-listen subscriptions that include unlimited access to the audio library and, in many markets, also eBooks. Differentiation from Audible (Amazon) comes through depth of local catalogue โ Storytel invests significantly in audio content production in Swedish, Danish, Norwegian, Finnish, and major European languages โ and a continuously evolving platform with personalisation and recommendation features.
Market & Clients
Geographic Presence
Similar Startups
Galdera Labs
Biotech company developing cell therapies and regenerative medicine treatments for serious diseases.
Read AnalysisRenasens AB
Waterless textile recycling technology that preserves fibre quality, transforming textile waste into clean, recycled fibres at industrial scale.
Read AnalysisMagnephy AB
Magnephy offers 3D microscopy at the nanometer scale and tissue analysis based on artificial intelligence for the development of preclinical and clinical drugs. Our technology reveals the effects of pathology and treatment with unprecedented detail to support data-driven research and development decisions.
Read AnalysisSources
- Storytel โ official website — www.storytel.com